Clinical Trials Browser

Recurrent Uterine Sarcoma × Imatinib Mesylate × Gynecologic × Clear all

NCT00075400 2019-07-24

Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer

Phase 2 Completed

26 enrolled 11 charts

GynecologicSarcoma

Recurrent Uterine Sarcoma